The Lancet Commission on prostate cancer: planning for the surge in cases

D. James, Nicholas; F. Tannock, Ian; N’Dow, James; Y. Feng, Felix; Gillessen, Silke; Adnan Ali, Syed; Trujillo, Blanca; Al‐Lazikani, Bissan; Attard, Gerhardt; Bray, Freddie; Compérat, Éva; A. Eeles, Rosalind; Fatiregun, Omolara; Grist, Emily; Halabi, Susan; Haran, Áine; Herchenhorn, Daniel; S. Hofman, Michael; Jalloh, Mohamed; Loeb, Stacy; Macnair, Archie; A. Mahal, Brandon; Mendes, Larissa; Moghul, Masood; M. Moore, Caroline; K. Morgans, Alicia; J. Morris, Michael; G. Murphy, Declan; Murthy, Vedang; L. Nguyen, Paul; R. Padhani, Anwar; Parker, Charles; Rush, Hannah; Sculpher, Mark; R. Soule, Howard; R. Sydes, Matthew; Tilki, Derya; Tunariu, Nina; Villanti, Paul; Xie, Liping

doi:10.1016/s0140-6736(24)00651-2

Public

The Lancet Commission on prostate cancer: planning for the surge in cases

Published in The Lancet • Apr 1, 2024

Authors:

Nicholas D. James

Ian F. Tannock

James N’Dow

Abstract

NDJ, RE, and CM are supported by the UK National Institute for Health and Care Research. Administrative support for the Commission was provided by the Institute of Cancer Research (London, UK), and by Pip Wilkinson in particular. Patient input was provided via Movember.

Subject

Life expectancy

Prostate cancer

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!